What will my estrone‑3‑glucuronide (E1G) level be tomorrow if implantation occurs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

E1G Levels and Implantation: What to Expect

I cannot predict your E1G level tomorrow based on the pattern you've described, because E1G (estrone-3-glucuronide) does not reliably change in response to implantation in a way that can be predicted from pre-implantation values 1, 2.

Why E1G Cannot Predict Implantation

E1G is a marker of ovarian follicular activity and estrogen production, not a marker of implantation. The hormone primarily reflects what your ovaries are doing—specifically, follicle development before ovulation and corpus luteum function after ovulation 1, 3, 4.

The Pattern You're Describing

Your E1G pattern shows:

  • Day 7 post-LH peak: 43.8 nmol/L
  • Day 8 post-LH peak: 129.9 nmol/L (a 3-fold rise)
  • Day 9 post-LH peak: 40.2 nmol/L (dropped back down)

This fluctuation is actually within the range of normal luteal phase variation that occurs in healthy ovulatory cycles, independent of whether implantation occurs 2. Studies show that 77% of normal ovulatory cycles differ from "mean curve patterns," with fluctuations, double peaks, and pre/post-peak surges being common 2.

What Happens at Implantation

Implantation (which typically occurs 6-12 days post-ovulation, or roughly 5-11 days post-LH peak) triggers hCG production by the developing embryo, not a predictable change in E1G 5, 6. The hCG then supports the corpus luteum to continue progesterone production, but E1G patterns during this window are highly variable and not diagnostic 1, 2.

The Hormone That Actually Indicates Implantation

If implantation has occurred, you should measure serum β-hCG (not E1G) starting around 9-11 days post-ovulation (roughly 8-10 days post-LH peak) 5, 6.

  • hCG becomes detectable in serum approximately 9 days after conception 5.
  • Urine pregnancy tests (detecting hCG at 20-25 mIU/mL) typically become positive 11 days past expected menses, which corresponds to roughly 11-14 days post-ovulation 5.
  • Serial hCG measurements 48 hours apart are far more useful than single values for confirming viable early pregnancy 6.

Expected hCG Pattern if Implantation Occurred

If implantation happened around days 6-9 post-LH peak:

  • Initial hCG rise begins within 24-48 hours of implantation 5.
  • hCG doubles approximately every 48-72 hours in viable early pregnancy 6.
  • By 10-12 days post-LH peak, serum hCG should be detectable (>5 mIU/mL) if implantation was successful 5, 6.

What Your E1G Pattern Actually Tells You

Your E1G fluctuation (43.8 → 129.9 → 40.2) most likely reflects normal luteal phase ovarian activity, not implantation status 1, 2. The rise and fall you observed is consistent with:

  • Secondary estrogen surges during the luteal phase, which occur in many normal cycles 2.
  • Day-to-day variability in steroid hormone excretion, which is common even in fertile cycles 2.
  • Corpus luteum function fluctuations, which produce variable E1G levels throughout the luteal phase 1, 4.

The Ratio That Matters More

The ratio of E1G to pregnanediol-3α-glucuronide (PdG) is more informative than E1G alone for assessing luteal phase adequacy 1, 4, 7. A declining E1G/PdG ratio after ovulation indicates adequate progesterone production, which is necessary (but not sufficient) for implantation 1, 4.

Bottom Line

Stop monitoring E1G to detect implantation—it won't work. Instead:

  1. Wait until at least 10-12 days post-LH peak (or first day of missed period) 5.
  2. Obtain a serum quantitative β-hCG test if you want the earliest possible detection 5, 6.
  3. Repeat the hCG measurement 48 hours later to confirm appropriate doubling (≥53% rise) if the first value is positive but low 6.
  4. Use a sensitive urine pregnancy test (detecting 20-25 mIU/mL) starting 11-14 days post-ovulation for home testing 5.

E1G tomorrow will reflect your ovarian activity, not implantation status, and could be anywhere from 20-150 nmol/L based on normal luteal phase variability 2, 4.

Related Questions

For an adult woman being evaluated for ovulation or undergoing assisted reproductive treatment, is an overnight first‑morning urine sample required for accurate estrone‑3‑glucuronide (E1G) measurement, or is a six‑hour collection without voiding sufficient?
Did I ovulate (based on LH peak 45 IU on cycle day 13, estrone‑glucuronide peak 288 ng/mL on day 13, and rising pregnanediol‑glucuronide) and if so when; when should I start progesterone supplementation for luteal‑phase insufficiency; and how long after ovulation remains the oocyte viable for fertilisation?
In a reproductive‑age woman tracking urinary estrone‑3‑glucuronide (E1G), does the level drop after embryo implantation or remain elevated/increase?
Is my estrone‑glucuronide (E1G) level of 43.8 µg on cycle day 20 (seven days after the LH surge) appropriate for early pregnancy while I am receiving progesterone supplementation?
Does estrone‑3‑glucuronide (E1G) dip during embryo implantation in a reproductive‑age woman?
What is the cyclophosphamide (Urolupus) regimen for severe proliferative lupus nephritis, including dosing schedules and adjunctive therapy?
How can manual muscle testing (MMT) be performed and graded in an unconscious patient?
Does apolipoprotein measurement or apomorphine therapy cause characteristic ECG changes?
What electrocardiographic abnormalities are seen in acute pulmonary edema?
Is it safe to administer morphine to a patient with multiple myeloma and impaired renal function (serum creatinine 2.2 mg/dL)?
What is the appropriate management for peripheral neuropathy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.